Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-56510 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-56510, RRID:AB_2148896
- Product name
- Mouse Monoclonal Myogenin Antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease.
CEP2 attenuates myoblast differentiation but does not affect proliferation.
Arsenic and Its Methylated Metabolites Inhibit the Differentiation of Neural Plate Border Specifier Cells.
Myocardin is sufficient for a smooth muscle-like contractile phenotype.
Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
Osaki T, Uzel SGM, Kamm RD
Nature protocols 2020 Feb;15(2):421-449
Nature protocols 2020 Feb;15(2):421-449
CEP2 attenuates myoblast differentiation but does not affect proliferation.
Wu M, Yang G, Chen Y, Zhou X, Chen H, Li M, Yu K, Zhang X, Xie S, Zhang Y, Chu G, Mo D
International journal of biological sciences 2015;11(1):99-108
International journal of biological sciences 2015;11(1):99-108
Arsenic and Its Methylated Metabolites Inhibit the Differentiation of Neural Plate Border Specifier Cells.
McCoy CR, Stadelman BS, Brumaghim JL, Liu JT, Bain LJ
Chemical research in toxicology 2015 Jul 20;28(7):1409-21
Chemical research in toxicology 2015 Jul 20;28(7):1409-21
Myocardin is sufficient for a smooth muscle-like contractile phenotype.
Long X, Bell RD, Gerthoffer WT, Zlokovic BV, Miano JM
Arteriosclerosis, thrombosis, and vascular biology 2008 Aug;28(8):1505-10
Arteriosclerosis, thrombosis, and vascular biology 2008 Aug;28(8):1505-10
Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
Dias P, Chen B, Dilday B, Palmer H, Hosoi H, Singh S, Wu C, Li X, Thompson J, Parham D, Qualman S, Houghton P
The American journal of pathology 2000 Feb;156(2):399-408
The American journal of pathology 2000 Feb;156(2):399-408
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: Myogenin Antibody (5FD) [NB100-56510] - Analysis of Myogenin expression in various small-round cell tumor lines. The antibody strongly reacted with a band at ~34 kDa in alveolar rhobdomyosarcoma line (Rh30). Negative cell lines were PFSK-1, EB2, SK-N-SH, and SJSA-1.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry: Myogenin Antibody (5FD) [NB100-56510] - Human myocytes using NB100-56703 at 2.5 ug/mL. Hematoxylin-eosin counterstain.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Frozen: Myogenin Antibody (5FD) [NB100-56510] - Analysis of Myogenin in human alveolar rhabdomyosarcoma using NB100-56510 at 5 ug/mL.